Neutrophil adhesion and direct cytotoxicity for cardiac myo-cytes require chemotactic stimulation and are dependent upon CD18-ICAM-1 binding. To characterize the potential role of IL-8 in this interaction, canine IL-8 cDNA was cloned and the mature recombinant protein expressed in Escherichia coli BL21 cells. Recombinant canine IL-8 markedly increased adhesion of neutrophils to isolated canine cardiac myocytes. This adhesion resulted in direct cytotoxicity for cardiac myocytes. Both processes were specifically blocked by antibodies directed against CD18 and IL-8. In vivo, after 1 h of coronary occlusion, IL-8 mRNA was markedly and consistently induced in reperfused segments of myocardium. IL-8 mRNA was not induced in control (normally perfused) myocardial segments. Minimal amounts of IL-8 mRNA were detected after 3 or 4 h of ischemia without reperfusion. Highest levels of induction were evident in the most ischemic myocardial segments. IL-8 mRNA peaked in the first 3 h of reperfusion and persisted at high levels beyond 24 h. IL-8 staining was present in the inflammatory infiltrate near the border between necrotic and viable myocardium, as well as in small veins in the same area. These findings provide the first direct evidence for regulation of IL-8 in ischemic and reperfused canine myocardium and support the hypothesis that IL-8 participates in neutrophil-mediated myocardial injury. (J. Clin. Invest. 1995. 95:89-103.)
Introduction
Substantial evidence indicates that chemotactic stimulation of CD18 adhesive functions is important in the mobilization of neutrophils into previously ischemic myocardium and in the extension of myocardial injury associated with reperfusion ( 1, 2) . This concept is based on reductions in neutrophil accumulation and postreperfusion injury by CD1 lb and CD18 blocking mAbs in models of myocardial ischemia and reperfusion (3) (4) (5) (6) (7) (8) (9) (10) , as well as on the activation of complement after myocardial ischemia (11) (12) (13) (14) (15) (16) . Furthermore, postischemic lymph is chemotactic for neutrophils as a result, at least in part, from CSa formation (16, 17) . In addition to complement, other chemotactic factors likely play a role in this process (1) . This is evidenced by recent studies where soluble complement receptor type-1, a potent inhibitor of both classic and alternative complement pathways, has failed to consistently inhibit neutrophil adhesion in reperfused myocardium (18, 19) .
We have shown previously that endothelial cell monolayers incubated with postreperfusion cardiac lymph produced all the factors necessary to induce adhesion of unstimulated neutrophils (20, 21) . Furthermore, when carefully observed under phasecontrast optics, a high percentage of neutrophils migrated beneath the endothelial monolayers, suggesting that activation of neutrophil motility had also occurred. Evidence provided by recent studies under similar in vitro conditions supports the conclusion that interleukin-8 (IL-8) may be directly responsible not only for inducing unstimulated neutrophil adhesion, but also for their transendothelial migration (22, 23) . IL-8 has potent chemotactic and proinflammatory functions (22) (23) (24) (25) and is more selective for neutrophils than C5a, platelet-activating factor, or leukotriene B4 (24, 26) . It appears that IL-8 is also important in activation of integrin adhesiveness and in directing leukocyte migration in vivo (24, 25, 27) . While the importance of IL-8 in models of ischemia and reperfusion has been recently suggested by the ability of anti-IL-8 antibodies to reduce lung parenchymal injury (28) , the participation of IL-8 in similar models in the myocardium has not been explored. In this report we seek to (a) characterize the role of recombinant canine IL-8 in neutrophil activation, adhesion, migration, and adhesiondependent reactive oxygen formation; and (b) establish the occurrence of IL-8 in post-reperfusion inflammation after coronary occlusion. The results in vitro demonstrate that IL-8 directly activates adhesion events and supports adhesion-dependent functions of the canine neutrophil. Our results also demonstrate that myocardial reperfusion initiates rapid induction of IL-8 in the previously ischemic tissue. Thus, IL-8 may mediate activation of neutrophil adhesiveness and motility in the context of myocardial reperfusion.
sequencer.
Canine IL-8 protein was expressed in Escherichia coli BL21 cells in two, 1-liter shake flasks. Expression was induced by overnight incubation with 500 MM isopropyl /3-D-thiogalactopyranoside (IPTG) , and the cells were harvested by centrifugation at 6,000 g before lysis. Cells were lysed by sonication in buffer containing 0.05 M Tris-HCl (pH 8.0), 5 mM EDTA, 5 mM DTT, 0.1% Triton X-100, and 0.1% PMSF. After lysis, the sonicated material was centrifuged, and the pellet was resuspended in buffer containing 0.05 M Tris-HCl (pH 8.0), 6 M guanidine-HCl, 50 mM D1T. The resolubilized protein was dialyzed against buffer containing 0.05 Tris-HCl (pH 8.0), 8 M urea , and loaded onto a S-Sepharose column equilibrated in 50 mM Mes (pH 5.0), 8 M urea. After loading, the column was washed with 50 mM Mes (pH 5.0) to remove the urea followed by an additional wash with buffer containing 50 mM Mes (pH 5.0), 500 mM NaCl. Fractions containing canine IL-8 were subjected to overnight refolding in the presence of 1 mM oxidized glutathione and 2 mM reduced glutathione. Extent of refolding was 1 . Abbreviations used in this paper: CJVEC, canine jugular vein endothelial cells; DCFH, 2 ',7' dichlorodihydrofluorescein diacetate; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; ICAM-1, intercellular adhesion molecule-1; KLH, Keyhole Limpet hemocyanin; ZAS, zymosan-activated dog serum. monitored by Poros analytical chromatography. Refolded dog IL-8 was subsequently purified by chromatography using C4 semi-preparative reverse phase HPLC using a 0-100% acetonitrile gradient in 0.1% TFA/H20. Fractions containing canine IL-8 were pooled and examined for purity by SDS-PAGE, analytical C4 HPLC, amino acid analysis, and NH2-terminal sequencing.
Determination of purity of canine IL-8. To confirm the identity of the purified protein and to assess the purity of the isolated protein species, electrospray ionization spectra were obtained. The electrospray ionization spectra were acquired by a single quadrupole mass spectrometer (Trio 2000; Fisons Instruments, Inc., Danvers, MA). The mass spectrometer was calibrated using horse heart myoglobin and scanned from m/z 600 to 1,600 in 10 s. The lyophilized samples were dissolved to their final concentration in a 1% acetic acid, methanol/water ( 1:1, vol/ vol) mixture, which was also used as the electrospray carrier solvent.
Protein solutions at concentrations of 10-50 pmol/Ml were injected (10 Ml) into the ion source at a flow rate of 10 l1/min.
Western analysis ofcanine IL-8. For analysis with mAb 5E7, chemokine protein samples (2 Mg) were electrophoresed on a 15% SDS polyacrylamide gel and subsequently blotted onto nitrocellulose matrix. After blocking, the blot was transferred to milk buffer containing 2.5 Mg/ml 5E7 monoclonal antibody. After removing unbound antibody, the blot was developed by standard procedures. For analysis with a rabbit polyclonal antibody anti-canine IL-8 0.5-ig chemokine samples were electrophoresed on a 14% tricine SDS polyacrylamide gel (31) and transferred to Immobilon-P filter (Millipore Corp., Bedford, MA). After blocking, the filter was incubated with the polyclonal anti-IL-8 (5 Mg/ ml) for 1 h. The filter was developed with enhanced chemiluminescence Western blotting analysis system (Amersham Corp.).
Neutrophil isolation. Canine neutrophils were isolated from citrate anticoagulated venous blood using techniques described previously for the isolation of human neutrophils (32) . This yielded a preparation of cells > 95% neutrophils with > 99% viability. These cells were suspended in Dulbecco's phosphate-buffered balanced salt solution (PBS) and used within 4 h.
Isolation of CJVEC. These cells were obtained by modification of the method of Ford (33), as described previously (21) . For adhesion assays, second passage cells were obtained by scraping, seeded onto gelatin-coated (0.1%) 25-mm round cover glasses, and grown to confluence.
Isolation ofcardiac myocytes. Previously described procedures were used (20, 21, 34) . Myocytes were isolated by retrograde perfusion of the canine myocardium through an aortic cannula. Perfusion with low calcium solution was followed by the addition of collagenase (120 U/ ml, type III; Worthington Biochemical Corp., Freehold, NJ). Preparations with a viability of > 80% were used in incubation experiments.
Cells were used within 5 h of isolation.
Shape change and chemotaxis assays. Shape change was determined on canine neutrophils as described previously ( 16, 17, 35 ). Suspensions of canine neutrophils were exposed to canine IL-8 for 5 min at 37°C and then fixed in 1.0% glutaraldehyde. The percentages of cells assuming spherical, ruffled, bipolar, and uropod configurations were then determined visually by phase-contrast microscopy ( X 100). The percentages of cells displaying ruffled, bipolar, and uropod configurations were added and reported as percent responsive neutrophils. For all antibody blocking studies, canine IL-8 and mAb 5E7 were coincubated for 20 min at room temperature before addition of cells.
Chemotactic migration was determined using the leading front assay as previously described (35) . Haptotactic migration was assessed by a modification to the method of Rot (36) . For Canine neutrophil adhesion to CJVEC monolayers and proteincoated glass. Confluent monolayers of CJVEC on glass coverslips were inserted into adhesion chambers, and the adhesion of isolated canine neutrophils was visually determined under static conditions as previously described (33, 37) . For adhesion to protein-coated glass, 25-mm round coverslips were spotted with 10 M1 of a Keyhole Limpet hemocyanin (KLH) solution (Sigma Chemical Co., St. Louis, MO) in PBS for 30 min at 37°C, rinsed in PBS by dipping six times, and mounted into the adhesion chambers as described previously (35, 38) . The percentage of neutrophils remaining attached to the CJVEC or to the KLH-coated glass was determined as described previously (35, 38) .
Canine neutrophil-myocyte adhesion. Adhesion was determined visually under static conditions as described previously (20, 34) . Myocytes were incubated in the presence or absence of human recombinant IL-1f3 (Genzyme Corp., Boston, MA) for 3 h at 37°C before addition of the neutrophils. Isolated canine neutrophils were prestimulated with canine IL-8 or I % zymosan-activated dog serum (ZAS) prepared as described ( 17) before use in adhesion assays.
Adhesion-dependent oxidation. Adhesion-dependent oxidation was determined as described previously (39) . Isolated myocytes were preincubated with human recombinant IL-ll as described above. Subsequently, they were loaded with 2',7'dichlorodihydrofluorescein diacetate (DCFH; Molecular Probes, Inc., Eugene, OR) for 20 min at 37°C and washed twice. DCFH-loaded myocytes were then suspended with canine neutrophils stimulated with canine IL-8 or ZAS, under identical circumstances to the protocol used for adhesion. Fluorometric studies were performed by monitoring cellular fluorescence in a fluorometer (Perkin-Elmer Cetus Instruments, Norwalk, CT; excitation 488 nm and emission of 521 nm).
Ischemia-reperfusion protocols. Healthy mongrel dogs ( 15-25 kg) of either sex were surgically instrumented as described previously (21 ) . Anesthesia was induced intravenously with 10 mg/kg methohexital sodium (Brevital; Eli Lilly and Co., Indianapolis, IN) and maintained with the inhalational anesthetic Isoflurane (Anaquest, Madison, WI). A midline thoracotomy provided access to the heart and mediastinum, and cannulation of the cardiac lymph duct was then performed (17) . Subsequently, a hydraulically activated occluding device and a Doppler flow probe ( 17, 21 ) were secured around the circumflex coronary artery just proximal or just distal to the first branch. Indwelling cannulae, placed in the right atrium, left atrium, and femoral artery, allowed blood sampling and pressure monitoring as needed.
The animals were allowed to recover for 72 h before occlusion. Ischemia-reperfusion protocols were performed in awake animals as described ( 17, 21) . Coronary artery occlusion was achieved by inflating the coronary cuff occluder until mean flow in the coronary vessel was zero, as determined by the Doppler flow probe. At the end of 1 h, the cuff was deflated and the myocardium was reperfused. Reperfusion intervals ranged from 1 to 24 h. Analgesia was accomplished with intravenously administered pentazocine (Talwin; Winthrop Pharmaceuticals, New York) 0.1-0.2 mg/kg.
After the reperfusion periods, hearts were stopped by the infusion of saturated potassium chloride and removed from the chest for sectioning from apex to base into four transverse rings -1 cm in thickness. Tissue samples were isolated from infarcted or normally perfused myocardium based on visual inspection. Myocardial segments were immediately frozen in liquid nitrogen. Frozen tissue samples were homogenized and processed in a blinded fashion for RNA isolation and analysis. Duplicate samples fixed in 10% buffered formalin were processed for blood flow determinations using radiolabeled microspheres as described previously (21, 40, 41) . All animal protocols were approved by the appropriate institutional review committee and conform to institutional guidelines.
Northern blots. RNA was isolated from myocardial tissue segments or cultured CJVEC using the acid guanidinium phenol chloroform procedure (42) . RNA (5-20 jg) was electrophoresed in 1% agarose gels containing formaldehyde, then transferred to a nylon membrane (Gene Screen Plus; New England Nuclear, Boston, MA) by standard procedures (21, 29) . Loading of RNA was monitored using ethidium bromide staining as well as by probing the nylon membranes with human glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Membranes were hybridized in QuikHyb rapid hybridization buffer (Stratagene), containing -1 x 106 dpmlml random hexamer 32P-labeled canine IL-8 cDNA probe at 680C for 2 h. The canine IL-8 cDNA probe consisted of a 1 ,100-bp fragment from the 3' untranslated region, obtained by restriction enzyme digestion from the isolated cDNA clone. After washing, filters were exposed to Hyperfilm-MP (Amersham Corp.) for 12-24 h. Analyses of radioactivity were performed on a blot analyzer (Betascope 603; Betagen, Waltham, MA) by scanning the blots for 90 min.
Polyclonal antibody to canine IL-8. A polyclonal antibody to canine IL-8 was made by immunizing rabbits with a 26-amino acid peptide from the COOH-terminal portion of canine IL-8. The peptide extended from Lys69 to Lys94 and it was synthesized in a peptide synthesizer (model 430; Applied Biosystems), using Fmoc chemistry according to the manufacturer's instructions. Purity of the peptide was assessed by amino acid analysis and HPLC. Three chinchilla rabbits were immunized. Each received 170 pg of peptide with 170 Mg of complete Freund's adjuvant divided into six intradermal sites. Rabbits were boosted according to the same protocol on days 9, 15, and 22. On day 29, the rabbits were killed. The serum was collected and in the first step desalted on Sephadex G25 column. The resulting peak was applied on DEAE Trisacryl M anion exchange column. The antibody-containing fraction eluted with the flow-through peak at three times the sample volume.
Immunohistochemistry. Samples were obtained immediately after the heart was removed from the animal and consist of 2-3-mm-thick sections extending transmurally through the anterior and posterior papillary muscles and the interventricular septum, and adjacent sections were taken from the midmyocardium parallel to the surface. These were placed in plastic embedding molds (Miles Lab-Tek, Naperville, IL) with OCT compound (Miles Inc., Elkhart, IN) and rapidly frozen in isopentane cooled to its freezing point with liquid nitrogen. Blocks were transferred to dry ice and stored at -70°C. Frozen sections 6-mm-thick Porcine: Rabbit: man, porcine, and rabbit IL-8 homologues (45) (46) (47) . After the NH2-terminal methionine, there is a positively charged 3-amino acid region that includes a lysine at amino acid position 4, followed by 15 hydrophobic residues, typical of n and h regions of a signal peptide (48). Based on the location of the NH2-terminal cleavage sites of human IL-8, the amino terminus of mature canine IL-8 could be at Glu2l, Ala23, or Val28 (49, 50) . Two putative signal peptidase cleavage sites that follow the -3, -1 rule were identified (48). These sites occur between residues 20 and 21, or 22 and 23, and would be compatible with two of the human IL-8 NH2-terminal forms. There is, however, significant evidence that IL-8 undergoes further NH2-terminal processing after cleavage of the signal peptide (49, 50 (57) . Canine IL-8 displayed significant sequence homology to human IL-8 at the amino acid level, being 75% identical overall. It also displayed high levels of amino acid homology to porcine and rabbit IL-8, being 85 and 80% identical, respectively (45-47) (Fig. 1 B) . All cysteine residues are conserved across the four species. There is also remarkable similarity with human, porcine, and rabbit IL-8 in terms of the signal peptide length and sequence, position of the predicted signal peptidase cleavage sites, and total length of the proteins (45) (46) (47) 58) .
Bacterial expression of canine IL-8. The recombinant protein was purified and refolded as described in Methods. Of the two coding sequences amplified, only the one encoding for the 75-amino acid protein starting at Val28 was expressed. The purified canine IL-8 was further characterized to establish the authenticity of the cDNA clone and purity of the recombinant product. To provide estimates of molecular mass, electrospray ionization spectra were obtained (Fig. 2 A) . This technique allows mass estimation of high resolution and accuracy. The predicted molecular mass of the 75-amino acid canine IL-8 is 8,709 with the NH2-terminal methionine and 8,577 without this residue. Two peaks were identified with mass estimates of 8,704 and 8,574. Within the 0.1% accuracy expected of this technique, these estimates correspond to the recombinant canine IL-8 with and without the NH2-terminal methionine. These findings were confirmed by NH2-tenrninal sequencing. Both forms of the recombinant canine IL-8 are present at almost equal proportions.
The corresponding Western blot performed with a murine monoclonal antibody to human recombinant IL-8 is shown in Fig. 2 B. As shown, mAb 5E7 reacts with both recombinant human and canine IL-8. A dominant band of -8 kD, corresponding to the monomeric form of both molecules, was demonstrated. In addition, a 16-kD band corresponding to the dimeric form of IL-8 was observed in both species. This higher molecular band was more intense in the preparation of human IL-8. 5E7 did not recognize the related chemokines GROa or platelet factor 4.
Biological activities ofcanine recombinant IL-8. Canine IL-8 induced the typical shape changes observed in neutrophils in suspension after chemotactic stimulation. In Fig. 3 pendent manner (Fig. 3 B) in all concentrations of canine IL-8 tested (Fig. 3 C) . Furthermore, this inhibition was not observed when isotype-matched antibodies to human 1L-8, such as mAb 5G9, that did not recognize canine IL-8 were used (Fig.  3 C) . Stimulation of neutrophils with canine 11L-8 significantly increased adhesion to monolayers of CJVEC or to KLH-coated glass in a concentration-dependent manner (Fig. 4) . Canine IL-8 also increased the cell surface expression of CD11 b on the neutrophil surface (Fig. 5) , as reported previously for human 11L-8 (59) . Exposure of neutrophils to IL-8 resulted in marked increases in adhesion to cardiac myocytes previously stimulated with IL-1,f to induce the surface expression of intercellular adhesion molecule-I (ICAM-1) (Fig. 6 A) . Peak adhesion was reached with 10 nM 1L-8. As shown, levels of adhesion induced by canine IL-8 were comparable to those observed after ZAS stimulation of the neutrophils. As previously reported, stimulation of both cell types appeared to be necessary since unstimulated neutrophils failed to adhere to IL-1-treated myocytes, and enhanced adhesion was not observed when 1L-1 was omitted (34) . Adhesion to cardiac myocytes was virtually eliminated when mAb R15.7 (anti-canine CD18) or mAb 5E7 was added to the reaction. Neutrophil-induced myocyte intracellular oxidative stress was studied using DCFH-loaded myocytes (39) . As shown in Fig. 6 (Fig. 7 A) . The haptotactic gradient of canine IL-8 had similar potency and efficacy as the chemotactic gradient. As was the case with shape change, 5E7 almost completely inhibited the extent of neutrophil migration (Fig. 7 B) .
Induction of IL-8 mRNA in CJVEC. Regulation of canine IL-8 mRNA was first studied in vitro in cultured CJVEC. The message was identified in Northern blot analyses as a 1.5-kb hybridizing band (Fig. 8) . Studies of the kinetic induction of IL-8 mRNA by TNF-a revealed marked increases after 30 min. Peak levels were reached after 3 h of stimulation. Steady state levels of IL-8 mRNA remained elevated above baseline levels even after 18 h of stimulation. This was consistent with the effects of TNF-a on human endothelial cells (60, 61 nine cell types examined and in myocardial segments after ischemia and reperfusion (data not shown). However, relative to the major transcript, the intensity of this band was never > 5%. This higher molecular weight band has also been observed in several human 11L-8 studies in a variety of cell types (62) (63) (64) (Fig. 9 A ) . Factors in cardiac lymph responsible for the induction of IL-8 mRNA on CJVEC appeared to be produced or released as a consequence of myocardial ischemic injury. This conclusion is based on the fact that lymph obtained from an experimental animal that underwent coronary occlusion and reperfusion but did not develop a myocardial infarction did not elicit IL-8 mRNA when incubated with CJVEC (Fig. 9 B) . Peak stimulatory activity for IL-8 in postischemic lymph was found within the first 3 h of reperfusion (Fig. 9 C) (Fig. 1, lanes B, E, G 
of this message (Fig. 11, lanes D Fig. 12 , the circumflex artery was occluded for 1 h, and then the myocardium was reperfused for 1, 3, or 24 h. Myocardial infarctions were evident in all three experiments. A time-dependent induction of IL-8 mRNA was observed in ischemic segments analyzed among each of these three animals. When comparing segments with similar degrees of blood flow reduction, steady state levels of IL-8 mRNA peaked within the first 3 h of reperfusion. IL-8 mRNA remained consistently elevated after 24 h of reperfusion, at levels as high as after the first hour of reperfusion. Expression of this message after 3 or 24 h of reperfusion was present only in ischemic and reperfused segments, whereas IL-8 mRNA was not evident in normally perfused anterior wall segments. Maximal induction was present in the most ischemic segments at all reperfusion intervals studied. Consistent with the observations after 1 h of reperfusion, experimental animals that were occluded and did not develop
an infarct failed to demonstrate measurable induction of IL-8 mRNA at time periods up to 24 h (data not shown).
Regulation ofIL-8 mRNA in the myocardium by reperfusion. The role of reperfusion in the induction of myocardial IL-8 mRNA was directly assessed in Fig. 13 . In contrast to the ischemic and reperfused segments, nonreperfused segments after 3 or 4 h of ischemia demonstrated only minimal induction of IL-8 mRNA, despite severe ischemia. The level of induction seen in the absence of reperfusion never exceeded 5-10% of equally ischemic segments with reperfusion. These findings are repre- sentative of four experiments analyzed after 3 or 4 h of continuous ischemia without reperfusion.
Development of anti-canine IL-8 polyclonal antibody. To evaluate the expression of IL-8 in the same experimental animals, an antibody capable of immunostaining myocardial sections was needed. A specific polyclonal antibody was made by immunizing rabbits with a synthetic 26-amino acid peptide based upon the deduced amino acid sequence of the carboxy terminus of canine IL-8 (see Methods). This polyclonal antibody recognized recombinant canine IL-8 in Western blots, without reacting with the related chemokine GROa (Fig. 14) . A much weaker band was also observed for human ( Fig. 14) .
Distribution ofIL-8 in ischemic and reperfused canine myocardium. Immunohistochemical studies of the IL-8 antigen in reperfused myocardium consistently showed distinct staining of the leukocytes which were present near the border between necrotic and viable myocardium (Fig. 15 A) . Staining of leukocytes was restricted to their cytoplasm. Staining of venular endothelium was also observed and was more often present in the vicinity of the inflammatory infiltrate than elsewhere. Positive staining of endothelium within small venules was often associated with the presence of neutrophils within the lumen or surrounding the vessel (Fig. 15 B) . Staining of arterial endothelium was not observed. After 1 or 3 h of ischemia without reperfusion staining for IL-8 was rarely seen (data not shown).
Discussion
Leukocyte migration into reperfused myocardium occurs in response to molecular events that signal injury or inflammation. In this report, we provide direct evidence that 11L-8 is induced in the myocardium as a result of experimental ischemia and reperfusion. These findings introduce a novel molecular signal present in reperfused myocardium and extend our previous ef- forts to unravel the molecular pathophysiology of the inflammatory response that follows myocardial reperfusion injury.
Structural and functional comparisons demonstrate canine and human IL-8 to be homologous proteins. Canine IL-8 shares 75% identity with human IL-8. In addition to this high level of homology, there are also remarkable similarities in terms of signal peptide length and sequence, position of the predicted signal peptidase cleavage sites, and total length of proteins. All cystein residues are conserved across both species, including those that conform to the CXC family configuration. In vitro, canine IL-8 has chemotactic and shape change dose-response profiles for canine neutrophils analogous to those of human IL-8 for both human and canine neutrophils (65, 66). As shown previously for human IL-8, canine IL-8 induces changes in the surface expression and function of CD1 lb/CD18 and is capable of eliciting neutrophil migration not only in solution but also when bound to the surface of a chemotaxis filter (36, 59 In these studies we documented that cellular events initiated by reperfusion of the previously ischemic myocardium consistently induced IL-8 mRNA in all segments that had been subjected to a significant degree of ischemia, while sparing the normally perfused control segments. The magnitude of blood flow reduction during coronary occlusion appeared to be a major determinant regulating the levels of IL-8 mRNA. The highest levels of induction were evident in the most ischemic myocardial segments. Furthermore, a graded response that closely paralleled the degree of ischemia was found in segments with mild and moderate reductions of blood flow. In animals in whom coronary occlusion did not affect ischemia because of extensive collateral blood flow, IL-8 mRNA induction was not detected. These findings were consistently evident regardless of the reperfusion interval. They are also in agreement with the observations of Dreyer et al. (8) (24, 62) . Hence, it is conceivable that different cell types are responsible for the production of IL-8 at different times during reperfusion and that a number of induction mechanisms may be involved in this process.
While it has been suggested that the constitutively expressed ICAM-1 on endothelial cells may be sufficient to support CD 18-dependent transendothelial migration of neutrophils (21, 71) , the requirement exists for a mechanism to direct neutrophil activation and transmigration to the injured areas of myocardium. Huber et al. (22) have shown that neutrophil transmigration across cytokine-stimulated endothelial cell monolayers occurs in response to a surface-bound IL-8 produced by the endo- (39) , and that myocyte contracture consistently occurred a few seconds after the peak of fluorescence (39) . Moreover, both adhesion and fluorescence depend primarily on CD11b/CD18 and ICAM-1 interactions (34, 37, 39) . Thus, 11L-8 may participate in the neutrophil-induced myocardial injury by inducing ligand-specific adhesion to cardiac myocytes, which in turn is required for a compartmented transfer of reactive oxygen species to cardiac myocytes (39) . Taken together these findings confirm our hypothesis that IL-8 is induced in reperfused myocardium and underscore the potential role of IL-8 in neutrophil activation and transmigration in previously ischemic myocardium. It is interesting to speculate that, under circumstances where blood flow may preclude the establishment of a stable soluble chemotactic gradient, a surface-bound chemoattractant may represent an effective mechanism of chemotactic agent presentation and of neutrophil activation. Parenchymal injury after lung ischemia and reperfusion has been prevented with the administration of anti-1L-8 antibodies (28) . It remains to be seen whether the same protection would occur in the heart. The results in this report are also consistent with the interpretation that sequential and overlapping patterns of chemoattractant generation, with varying degrees of cell specificity, are likely to occur in vivo after reperfusion of the previously ischemic myocardium.
